|Articles|April 4, 2019
WCG Announces Acquisition of Analgesic Solutions
Advertisement
The WIRB-Copernicus Group’s Clinical Services Division announced the acquisition of Analgesic Solutions. Analgesic Solutions focuses on developing new pain medications and improving the quality of pain management clinical trials.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Novo Nordisk’s Phase III OASIS 4 Analyses Highlight Cardiometabolic Benefits of Oral Semaglutide 25 mg
2
FDA Approves Caplyta as Adjunctive Therapy for Major Depressive Disorder Based on Positive Phase III Results
3
ACT Brief: Designing Feasible Protocols and Breakthroughs in Obesity and Metabolic Research
4
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
